Australia

Decision Governance to Enhance Accountability and Transparency of Decisions in Enterprises

The decision governance gap was always there. AI agents just made it impossible to ignore. MELBOURNE, Australia, May 19, 2026 /PRNewswire/ -- FlexRule makes the case that accountability, explainability, and decision quality are not AI problems. They are governance problems that enterprises have ...

2026-05-19 13:52 2641

DAVE & BUSTER'S OPENS IN PERTH AS BRAND CONTINUES GLOBAL EXPANSION

Dave & Buster's makes its Australia debut, expanding its Asia-Pacific footprint Key Highlights * First Dave & Buster's location in Australia opens in Perth. * New venue combines dining, sports viewing and competitive social gaming under one roof. * The opening advances Dave & Buster's conti...

2026-05-19 04:01 2825

Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board

* RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerabilityto date. * Dr. Coulie brings more than 25 years of international biopharma leadership and deep expertise in pulmonary disease to the Atisama Board of Directors. MELBOURNE, Australia...

2026-05-15 22:25 8471

Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial

Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced solid tumor patients SYDNEY, May 15, 2026 /PRNewswire/ -- Racura Oncology, an Australian Phase 3 stage clinical biopharmaceutical company, today ...

2026-05-15 19:06 4310

EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder

* US$13.75M financing completed to accelerate clinical pathway and global commercialisation * Establishment of NinaMED Pty Ltd, a new Australian medtech company * NinaMED Pty Ltd secures a license from EBT Medical for exclusive global rights to NiNA System®, a non‑invasive, at‑home OAB thera...

2026-05-14 13:03 2510

Razor Labs Wins Gold Globee® Award for AI Innovation in Mining Fleet Reliability

DataMind AI™ for mobile fleet recognized in the "Anomaly Detection & Pattern Recognition Platform" category SYDNEY, May 12, 2026 /PRNewswire/ -- Razor Labs (TASE: RZR), a global leader in AI-powered predictive maintenance solutions for the mining industry, today announced that it has been named ...

2026-05-12 06:00 2556

(E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression

Preclinical studies have highlighted how (E,E)-bisantrene silences c-MYC gene expression via G4-DNA binding and stabilization leading to clinically relevant and broad anticancer activity SYDNEY, May 6, 2026 /PRNewswire/ -- Racura Oncology, an Australian Phase 3 stage clinical biopharmaceutical c...

2026-05-06 19:00 3673

Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1

* PEDMARQSI® is now TGA registered in Australia for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid tumours * TGA registration provides an approved treatment option in an area of significant unmet me...

2026-05-06 05:01 3233

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

* Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen to be approved in Australia for adults with relapsed or refractory follicular lymphoma (R/R FL) (Grade 1-3a).1,2 * De...

2026-04-23 15:00 3338

Proudly Human announces Manager Tools as the world's first officially certified podcast as the world struggles to distinguish between AI-generated and human-created content

SYDNEY, April 22, 2026 /PRNewswire/ -- Proudly Human has announced its certification of all content from global company Manager Tools as human-created, including its three award-winning podcasts, training, and books. This is the first time either a podcast or a p...

2026-04-22 20:32 2787

TeamHive Launches Free Team Effectiveness Indicator, Giving Any Leader or Team Member Instant, Research-Backed Insight Into How Their Team Really Works

HR tech platform, validated by the University of Newcastle, makes its PLUS model diagnostic available at no cost to teams worldwide SYDNEY, April 21, 2026 /PRNewswire/ -- TeamHive (https://team-hive.co/ ), the evidence-based team effectiveness platform, today announced the...

2026-04-22 03:15 2697

Seeing Machines Releases Part 2 of Technical Paper Series on Intoxication

Driver Monitoring System technology enables real-time assessment of a driver's functional state relative to the driving environment CANBERRA, Australia, April 21, 2026 /PRNewswire/ -- Seeing Machines Limited, a global leader in vision-based monitoring technology, has released the second part of ...

2026-04-21 14:00 2636

Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the appointment of Dr. Sudha Rao as Chief Scientific Officer (CSO). Dr. Rao is the scientific originat...

2026-04-15 20:00 5639

Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma

SYDNEY, April 14, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Com...

2026-04-14 21:02 4134

Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis

WILMINGTON, Del., April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase IIa clinical trial of HXN-1001, a half-life extended anti-TL1A antibody, in patients with ulcerative c...

2026-04-02 19:00 4898

Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics

SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a lar...

2026-03-25 21:01 5423

Breaking the Design Barrier: X-Design Evolves into Zawa, Launching a Dedicated Creative AI Agent for Branding

From "democratizing design" to "systematizing growth," Zawa's new "Zero to Wow" philosophy redefines the future of visual automation for SMBs and local merchants. SYDNEY, March 18, 2026 /PRNewswire/ -- X-Design, the pioneering platform that made professional design accessible to everyone, today ...

2026-03-19 03:39 4855

Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal

HIGHLIGHTS * Oral presentation on key results from the Co-PSMA (NCT06907641 )[1] Investigator-Initiated Trial (IIT) was delivered by ProfLouise Emmett (St Vincent's Hospital Sydney) at the European Association of Urology (EAU) Congress 2026 on the ...

2026-03-17 21:01 6157

Trial to test mild hyperbaric oxygen therapy during active treatment for aggressive brain cancer

LISMORE, Australia, March 15, 2026 /PRNewswire/ -- Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating whether hyperbaric oxygen therapy (HBOT) can safely support patients undergoing treatment f...

2026-03-16 09:43 3400

Vmake Video Enhancer Introduces "AI 4K+": Setting a New Standard in AI Video Enhancement

SYDNEY, March 10, 2026 /PRNewswire/ -- Vmake recently announced a major upgrade to VmakeVideo Enhancer , introducing AI 4K+, a new enhancement mode designed to deliver sharper, more natural-looking upscales for creators and businesses who need premium video qualit...

2026-03-11 01:00 4475
12345 ... 45